Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
22.10
+0.66 (3.08%)
Dec 18, 2025, 4:00 PM EST - Market closed

Nanobiotix Revenue

Nanobiotix had revenue of 13.32M EUR in the half year ending June 30, 2025, with 186.77% growth. This brings the company's revenue in the last twelve months to 10.16M, down -75.93% year-over-year. In the year 2024, Nanobiotix had annual revenue of -7.19M.

Revenue (ttm)
10.16M EUR
Revenue Growth
-75.93%
P/S Ratio
88.74
Revenue / Employee
94,056 EUR
Employees
108
Market Cap
1.06B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.10%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-243.00K-6.53%
Dec 31, 20173.72M-1.70M-31.35%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M1.18M73.67%
Dec 31, 20131.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings